NFKB1 and cancer: Met may mitigate the detrimental effects triggered by this 50 Hz MF on the aged mouse fibroblasts by modulating the EMT entities and NF‐kB, which possibly plays a crucial role in the development of 50 Hz MF‐induced carcinogenesis and hence might be a future therapeutic candidate for treating MF‐induced cancer.